Effect of metformin on plasma fibrinogen concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials

Luis E. Simental-Mendía, Matteo Pirro, Stephen Atkin, Maciej Banach, Dimitri P. Mikhailidis, Amirhossein Sahebkar

Research output: Contribution to journalReview article

Abstract

Objective: Fibrinogen is a key mediator of thrombosis and it has been implicated in the pathogenesis of atherosclerosis. Because metformin has shown a potential protective effect on different atherothrombotic risk factors, we assessed in this meta-analysis its effect on plasma fibrinogen concentrations. Methods: A systematic review and meta-analysis was carried out to identify randomized placebo-controlled trials evaluating the effect of metformin administration on fibrinogen levels. The search included PubMed-Medline, Scopus, ISI Web of Knowledge and Google Scholar databases (by June 2, 2017) and quality of studies was performed according to Cochrane criteria. Quantitative data synthesis was conducted using a random-effects model and sensitivity analysis by the leave-one-out method. Meta-regression analysis was performed to assess the modifiers of treatment response. Results: Meta-analysis of data from 9 randomized placebo-controlled clinical trials with 2302 patients comprising 10 treatment arms did not suggest a significant change in plasma fibrinogen concentrations following metformin therapy (WMD:-0.25 g/L, 95% CI:-0.53, 0.04, p = 0.092). The effect size was robust in the leave-one-out sensitivity analysis and remained non-significant after omission of each single study from the meta-analysis. Conclusion: No significant effect of metformin on plasma fibrinogen concentrations was demonstrated in the current meta-analysis.

Original languageEnglish
Pages (from-to)1034-1040
Number of pages7
JournalCurrent Pharmaceutical Design
Volume24
Issue number9
DOIs
Publication statusPublished - 1 Jan 2018

Fingerprint

Metformin
Fibrinogen
Meta-Analysis
Randomized Controlled Trials
Placebos
PubMed
Atherosclerosis
Thrombosis
Therapeutics
Regression Analysis
Databases

Keywords

  • Coagulation
  • Fibrinogen
  • Hemostasis
  • Meta-analysis
  • Metformin
  • Thrombosis

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Cite this

Effect of metformin on plasma fibrinogen concentrations : A systematic review and meta-analysis of randomized placebo-controlled trials. / Simental-Mendía, Luis E.; Pirro, Matteo; Atkin, Stephen; Banach, Maciej; Mikhailidis, Dimitri P.; Sahebkar, Amirhossein.

In: Current Pharmaceutical Design, Vol. 24, No. 9, 01.01.2018, p. 1034-1040.

Research output: Contribution to journalReview article

Simental-Mendía, Luis E. ; Pirro, Matteo ; Atkin, Stephen ; Banach, Maciej ; Mikhailidis, Dimitri P. ; Sahebkar, Amirhossein. / Effect of metformin on plasma fibrinogen concentrations : A systematic review and meta-analysis of randomized placebo-controlled trials. In: Current Pharmaceutical Design. 2018 ; Vol. 24, No. 9. pp. 1034-1040.
@article{ac3e790a2a634e3c8123ed3f517f3e11,
title = "Effect of metformin on plasma fibrinogen concentrations: A systematic review and meta-analysis of randomized placebo-controlled trials",
abstract = "Objective: Fibrinogen is a key mediator of thrombosis and it has been implicated in the pathogenesis of atherosclerosis. Because metformin has shown a potential protective effect on different atherothrombotic risk factors, we assessed in this meta-analysis its effect on plasma fibrinogen concentrations. Methods: A systematic review and meta-analysis was carried out to identify randomized placebo-controlled trials evaluating the effect of metformin administration on fibrinogen levels. The search included PubMed-Medline, Scopus, ISI Web of Knowledge and Google Scholar databases (by June 2, 2017) and quality of studies was performed according to Cochrane criteria. Quantitative data synthesis was conducted using a random-effects model and sensitivity analysis by the leave-one-out method. Meta-regression analysis was performed to assess the modifiers of treatment response. Results: Meta-analysis of data from 9 randomized placebo-controlled clinical trials with 2302 patients comprising 10 treatment arms did not suggest a significant change in plasma fibrinogen concentrations following metformin therapy (WMD:-0.25 g/L, 95{\%} CI:-0.53, 0.04, p = 0.092). The effect size was robust in the leave-one-out sensitivity analysis and remained non-significant after omission of each single study from the meta-analysis. Conclusion: No significant effect of metformin on plasma fibrinogen concentrations was demonstrated in the current meta-analysis.",
keywords = "Coagulation, Fibrinogen, Hemostasis, Meta-analysis, Metformin, Thrombosis",
author = "Simental-Mend{\'i}a, {Luis E.} and Matteo Pirro and Stephen Atkin and Maciej Banach and Mikhailidis, {Dimitri P.} and Amirhossein Sahebkar",
year = "2018",
month = "1",
day = "1",
doi = "10.2174/1381612823666171103165502",
language = "English",
volume = "24",
pages = "1034--1040",
journal = "Current Pharmaceutical Design",
issn = "1381-6128",
publisher = "Bentham Science Publishers B.V.",
number = "9",

}

TY - JOUR

T1 - Effect of metformin on plasma fibrinogen concentrations

T2 - A systematic review and meta-analysis of randomized placebo-controlled trials

AU - Simental-Mendía, Luis E.

AU - Pirro, Matteo

AU - Atkin, Stephen

AU - Banach, Maciej

AU - Mikhailidis, Dimitri P.

AU - Sahebkar, Amirhossein

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Objective: Fibrinogen is a key mediator of thrombosis and it has been implicated in the pathogenesis of atherosclerosis. Because metformin has shown a potential protective effect on different atherothrombotic risk factors, we assessed in this meta-analysis its effect on plasma fibrinogen concentrations. Methods: A systematic review and meta-analysis was carried out to identify randomized placebo-controlled trials evaluating the effect of metformin administration on fibrinogen levels. The search included PubMed-Medline, Scopus, ISI Web of Knowledge and Google Scholar databases (by June 2, 2017) and quality of studies was performed according to Cochrane criteria. Quantitative data synthesis was conducted using a random-effects model and sensitivity analysis by the leave-one-out method. Meta-regression analysis was performed to assess the modifiers of treatment response. Results: Meta-analysis of data from 9 randomized placebo-controlled clinical trials with 2302 patients comprising 10 treatment arms did not suggest a significant change in plasma fibrinogen concentrations following metformin therapy (WMD:-0.25 g/L, 95% CI:-0.53, 0.04, p = 0.092). The effect size was robust in the leave-one-out sensitivity analysis and remained non-significant after omission of each single study from the meta-analysis. Conclusion: No significant effect of metformin on plasma fibrinogen concentrations was demonstrated in the current meta-analysis.

AB - Objective: Fibrinogen is a key mediator of thrombosis and it has been implicated in the pathogenesis of atherosclerosis. Because metformin has shown a potential protective effect on different atherothrombotic risk factors, we assessed in this meta-analysis its effect on plasma fibrinogen concentrations. Methods: A systematic review and meta-analysis was carried out to identify randomized placebo-controlled trials evaluating the effect of metformin administration on fibrinogen levels. The search included PubMed-Medline, Scopus, ISI Web of Knowledge and Google Scholar databases (by June 2, 2017) and quality of studies was performed according to Cochrane criteria. Quantitative data synthesis was conducted using a random-effects model and sensitivity analysis by the leave-one-out method. Meta-regression analysis was performed to assess the modifiers of treatment response. Results: Meta-analysis of data from 9 randomized placebo-controlled clinical trials with 2302 patients comprising 10 treatment arms did not suggest a significant change in plasma fibrinogen concentrations following metformin therapy (WMD:-0.25 g/L, 95% CI:-0.53, 0.04, p = 0.092). The effect size was robust in the leave-one-out sensitivity analysis and remained non-significant after omission of each single study from the meta-analysis. Conclusion: No significant effect of metformin on plasma fibrinogen concentrations was demonstrated in the current meta-analysis.

KW - Coagulation

KW - Fibrinogen

KW - Hemostasis

KW - Meta-analysis

KW - Metformin

KW - Thrombosis

UR - http://www.scopus.com/inward/record.url?scp=85048967447&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85048967447&partnerID=8YFLogxK

U2 - 10.2174/1381612823666171103165502

DO - 10.2174/1381612823666171103165502

M3 - Review article

AN - SCOPUS:85048967447

VL - 24

SP - 1034

EP - 1040

JO - Current Pharmaceutical Design

JF - Current Pharmaceutical Design

SN - 1381-6128

IS - 9

ER -